3.0
10. Sept. 2012
Aktueller Mitarbeiter, mehr als 10 Jahre
South San Francisco, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Medical, Dental are good. People are friendly Nice campus Good Commute options like Genenbus but poor vanpool support.
Kontras
Roche acquisition has damaged the company to a point of no return. Management is poor. Compensation not competative. Hard to get promoted. Senior employees and scientists are leaving the company. Roche stifles creativity and independent thinking. Mistakes are not considered opportunities to grow and learn. Empolyees not promoted from within. Mangers often do not know the job/work which leads to wrong decision making. There is a new environment of hierarchy, ie decisions are top down, there is a new attitude that degrees mean more than on the job experience.